A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Clinical trial NCT07227454 · RECRUITING

Trial details

NCT number: NCT07227454
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2026-01-08
Primary completion: 2031-04-09
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.